Biosimilars

The opportunity offered by biosimilars is still unfolding. But the value they can offer is clear - Scott Gottlieb

Biosimilars
Biosimilars

image by: The Center for Biosimilars

HWN Suggests

The Case For Letting Biosimilars Compete

As policy makers try to address unsustainable prices for biologic drugs, concerns about the fledgling US market for biosimilars have come to the forefront. Some experts have even suggested abandoning biosimilars in favor of more heavy-handed mechanisms to lower the prices of biologics. We agree that there are unique barriers to biosimilar competition. Giving up on the biosimilars market while it is still in its infancy, however, would be a detriment to both patients and the health care system as a whole.

Kaiser Permanente knows from experience that biosimilars have significant value. We successfully use biosimilars to improve affordability for patients, saving our system millions of…

read full article

Resources

 The Case For Letting Biosimilars Compete

As policy makers try to address unsustainable prices for biologic drugs, concerns about the fledgling US market for biosimilars have come to the forefront. Some experts have even suggested abandoning biosimilars in favor of more heavy-handed mechanisms to lower the prices of biologics. We agree that there are unique barriers to biosimilar competition. Giving up on the biosimilars market while it is still in its infancy, however, would be a detriment to both patients and the health care system as a whole.

The Center for Biosimilars

he mission of the Center for Biosimilars is to leverage, build, and support the authoritative voices that advance understanding of emerging therapies and to address the existing gap between clinical and health economic data.

Big Molecule Watch

Big Molecule Watch will be posting updates and analyses on regulatory issues, litigation, legislation, and other news in the ever-developing world of biosimilars.

Biosimilar Development

The landscape of the life sciences industry is as vast and varied as the professionals who work in it. Some online resources aim to serve the entire space. We wish them luck. Instead, our goal is to be the most valuable resource for a specific segment of the industry – biosimilars – and the professionals who make their living there.

Biosimilars Council

The Biosimilars Council works to ensure a positive regulatory, reimbursement, political and policy environment for biosimilar products, and will educate the public and patients about the safety and effectiveness of biosimilars.

Safe Biologics

It is the mission of the Alliance to serve as an authoritative resource center for the public, medical community, the U.S. Food and Drug Administration and government regulators worldwide as biosimilars policies are developed and implemented.

Introducing Stitches!

Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!

Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.


Be the first to know when Stitches starts accepting users


Stay Connected